HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TENNOR THERAP-B

136.400

-13.400-8.95%

Volume:176.15K

Turnover:25.78M

Market Cap:7.14B

PE:-35.47

High:158.000

Open:148.600

Low:132.300

Close:149.800

52wk High:287.000

52wk Low:132.300

Shares:52.33M

HK Float Shares:52.33M

Volume Ratio:1.44

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.845

ROE:--

ROA:-41.38%

PB:9.33

PE(LYR):-35.47

PS:- -

Loading ...

Overview Company News Filings

IPO Margin Financing Statistics as of May 18th

IPO Margin Financing Statistics as of May 15

Global First-in-Class Drug's Robust Capabilities Lead the Way, TENNOR THERAP-B (06872) Initiates IPO to Tap into the Anti-Infective Market

IPO Margin Financing Data as of May 14

New Stock Alert: TENNOR THERAPEUTICS-B (06872), the "H. pylori Nemesis," Attracts Strong Investor Interest in IPO

TenNor Therapeutics Launches Up to HK$627 Million Hong Kong IPO

MT Newswires Live

天诺医药完成全球发售：每股发售价HK$75.70，发行逾828万股H股

Bulletin Express

TenNor Therapeutics Sets HK$75.70 Offer Price for Hong Kong IPO, Targeting HK$626.84 Million Raise

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/06872/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06872","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","market":"HK","secType":"STK","nameCN":"TENNOR THERAP-B","latestPrice":136.4,"timestamp":1789027722331,"preClose":149.8,"halted":0,"volume":176150,"delay":0,"changeRate":-0.08945260347129509,"floatShares":52328926,"shares":52328926,"eps":-3.845134,"marketStatus":"Not Yet Opened","change":-13.4,"latestTime":"09-10 16:08:42","open":148.6,"high":158,"low":132.3,"amount":25781120,"amplitude":0.171562,"askPrice":136.4,"askSize":300,"bidPrice":135.1,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-3.065,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1779379200000,"exchange":"SEHK","adjPreClose":149.8,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.443168729085907,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","floatShares":52328926,"roa":"-41.38%","roe":"--","lyrEps":-3.845134,"volumeRatio":1.443168729085907,"shares":52328926,"dividePrice":0,"high":158,"amplitude":0.171562,"preClose":149.8,"low":132.3,"week52Low":132.3,"pbRate":"9.33","week52High":287,"institutionHeld":0,"latestPrice":136.4,"committee":-0.714286,"eps":-3.845134,"divideRate":0,"volume":176150,"delay":0,"ttmEps":-3.065,"open":148.6,"prevYearClose":75.7,"prevWeekClose":168,"prevMonthClose":188.2,"prevQuarterClose":218.6,"fiveDayClose":173.8,"twentyDayClose":199.5,"sixtyDayClose":254},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06872\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"06872","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06872\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06872\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06872\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06872","date":"2026-09-09","current":-44.502447,"percent":0.96,"low":-79.827178,"twenty":-63.218073,"median":-58.733667,"eighty":-53.687748,"high":-22.197537,"avg":-59.237919,"sd":9.052548,"marketCap":7838873114},"quantilePoints":[{"date":"2026-05-22","current":-61.8716,"twenty":-53.936788,"median":-42.034569,"eighty":-30.13235,"marketCap":10919983436},{"date":"2026-05-29","current":-59.494815,"twenty":-62.838158,"median":-61.618293,"eighty":-59.494815,"marketCap":10537007713},{"date":"2026-06-05","current":-62.851725,"twenty":-62.838158,"median":-60.050534,"eighty":-58.89743,"marketCap":11147698730},{"date":"2026-06-12","current":-76.559316,"twenty":-67.151261,"median":-61.677494,"eighty":-59.494815,"marketCap":13569761407},{"date":"2026-06-18","current":-77.133424,"twenty":-72.687664,"median":-62.661499,"eighty":-59.556904,"marketCap":13704320444},{"date":"2026-06-26","current":-70.955051,"twenty":-75.200431,"median":-67.151261,"eighty":-59.954912,"marketCap":12545042582},{"date":"2026-07-03","current":-58.617008,"twenty":-74.357411,"median":-63.947365,"eighty":-59.541382,"marketCap":10371396590},{"date":"2026-07-10","current":-60.15333,"twenty":-73.973221,"median":-62.661499,"eighty":-59.255861,"marketCap":10630163970},{"date":"2026-07-17","current":-55.825344,"twenty":-72.988779,"median":-61.483388,"eighty":-58.84852,"marketCap":9900439958},{"date":"2026-07-24","current":-49.131605,"twenty":-71.514675,"median":-60.732749,"eighty":-58.099276,"marketCap":8715285358},{"date":"2026-07-31","current":-46.679708,"twenty":-70.790774,"median":-60.234228,"eighty":-52.553459,"marketCap":8296082202},{"date":"2026-08-07","current":-55.366509,"twenty":-69.892278,"median":-60.050534,"eighty":-50.857587,"marketCap":9859037178},{"date":"2026-08-14","current":-57.79283,"twenty":-68.864339,"median":-59.266767,"eighty":-52.426498,"marketCap":10304117071},{"date":"2026-08-21","current":-57.375761,"twenty":-68.134271,"median":-58.89743,"eighty":-52.755376,"marketCap":10252363595},{"date":"2026-08-28","current":-60.609482,"twenty":-65.869703,"median":-58.836292,"eighty":-53.963985,"marketCap":9848303873},{"date":"2026-09-04","current":-54.082397,"twenty":-63.655648,"median":-58.89743,"eighty":-54.200774,"marketCap":8791259568},{"date":"2026-09-09","current":-48.146411,"twenty":-63.218073,"median":-58.733667,"eighty":-53.687748,"marketCap":7838873114}],"updateTime":1789078977597},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06872\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153935163","title":"IPO Margin Financing Statistics as of May 18th","url":"https://stock-news.laohu8.com/highlight/detail?id=1153935163","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153935163?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:22","pubTimestamp":1779103337,"startTime":"0","endTime":"0","summary":"As of May 18th, several companies are in the process of IPO subscription, including TENNOR THERAP-B (06872), SDMC (00901), DEEPZERO (02723), and VIEWTRIX TECH (03310). According to data from brokers...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03310","00901","06872","02723","BK1156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198076775","title":"IPO Margin Financing Statistics as of May 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1198076775","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198076775?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:46","pubTimestamp":1778841994,"startTime":"0","endTime":"0","summary":"UISEE TECH (01511) and TOPNC (07688) have concluded their public offerings, while TENNOR THERAP-B (06872) remains in the subscription period. As of May 15, data from brokers including Futu Securities...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01511","07688","IPOS","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175846770","title":"Global First-in-Class Drug's Robust Capabilities Lead the Way, TENNOR THERAP-B (06872) Initiates IPO to Tap into the Anti-Infective Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1175846770","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175846770?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:34","pubTimestamp":1778834058,"startTime":"0","endTime":"0","summary":"In recent years, the capital market's scrutiny of innovative pharmaceutical companies has deepened. While the HKEX's Chapter 18A rules have opened a financing path for pre-profit biotech firms, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159992","IPOS","06872","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195802362","title":"IPO Margin Financing Data as of May 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1195802362","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195802362?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:47","pubTimestamp":1778755639,"startTime":"0","endTime":"0","summary":"UISEE TECH (01511), TOPNC (07688), and TENNOR THERAP-B (06872) are currently in the process of their initial public offerings. As of May 14, brokerages including Futu Securities and Tiger Brokers...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01511","06872","07688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152867865","title":"New Stock Alert: TENNOR THERAPEUTICS-B (06872), the \"H. pylori Nemesis,\" Attracts Strong Investor Interest in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1152867865","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152867865?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:17","pubTimestamp":1778750268,"startTime":"0","endTime":"0","summary":"TENNOR THERAPEUTICS-B (06872), known as the \"H. pylori nemesis,\" is conducting its initial public offering from May 14 to May 19, 2026. According to the prospectus, the company is a biotechnology...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635763799","title":"TenNor Therapeutics Launches Up to HK$627 Million Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2635763799","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635763799?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:06","pubTimestamp":1778724388,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics  launched its Hong Kong initial public offering on Thursday, seeking to raise about HK$626.8 million from the deal.The China-based near-commercial stage biotechnology company is offering 8.3 million shares at HK$75.70 each, according to a Hong Kong bourse filing.The offering comprises 828,100 shares for Hong Kong investors and 7.5 million shares for international investors, subject to reallocation, the offer size adjustment option, and the overallotment option.Allocation results are due by May 21, ahead of the company's planned trading debut on May 22.Net proceeds will be used mainly to fund the research, development, regulatory filings, and commercialization of core products rifasutenizol and rifaquizinone injection.The funds will also be used to support clinical development of TNP-2092, advance other pipeline candidates, construct an in-house manufacturing facility in Guangdong, and for working capital and general corporate purposes.CITIC Securities  and ABCI Capi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPCX","LENZ","06872","BK4139","BK4539","IPOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195346924","title":"天诺医药完成全球发售：每股发售价HK$75.70，发行逾828万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195346924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195346924?lang=en_us&edition=fundamental","pubTime":"2026-05-14 06:32","pubTimestamp":1778711568,"startTime":"0","endTime":"0","summary":"-- 公司概况 --   天诺医药（苏州）有限公司（下称“天诺医药”）主要从事细菌感染及细菌代谢相关疾病的药物研发，拥有多项临床及在研管线，聚焦未被满足的临床需求。公司自2012年起逐步完成多轮融资，股东结构涵盖境内外基金、创投机构及个人投资者，并于2025年6月转制为股份有限公司，为全球发售做好准备。 -- 行业概况 --...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"天诺医药完成全球发售：每股发售价HK$75.70，发行逾828万股H股","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108359656","title":"TenNor Therapeutics Sets HK$75.70 Offer Price for Hong Kong IPO, Targeting HK$626.84 Million Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=1108359656","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108359656?lang=en_us&edition=fundamental","pubTime":"2026-05-14 06:25","pubTimestamp":1778711112,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited will offer 8.28 million H shares at HK$75.70 each in its upcoming Hong Kong listing, implying gross proceeds of approximately HK$626.84 million before any...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":48,"code":"91000000","status":"200"}]}}